Get started
Work

Abstract PS4-02-20: Clinical and genomic biomarkers of capivasertib response in patients with hormone receptor-positive, HER2-negative metastatic breast cancer (HR+/HER2- MBC)

Year: 2026
Type: conference-abstract
DOI: 10.1158/1557-3265.sabcs25-ps4-02-20
Authors: M. R. Lloyd, E. L. Podany, Z. Bagheri, E. Rizk, A. Dedeoglu, A. Putur, C. Ping, J. Hesse, A. Golden, S. Addison, J. J. Tao, N. Vidula, R. O. Abelman, K. K. Clifton, I. Sanidas, A. Varkaris, D. Juric, N. Vasan, C. X. Ma, G. M. Wulf, L. W. Ellisen, S. A. Wander
Institutions: Beth Israel Deaconess Medical Center, Washington University in St. Louis, Harvard University, Massachusetts General Hospital, Columbia University Irving Medical Center, Columbia University, NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W7129544440
Cites:
Cited by:
Related to: